Skip to main content
. 2018 Oct 5;20(10):1464–1472. doi: 10.1111/jch.13375

Figure 3.

Figure 3

Use and Association of β‐blockers With Clinically Relevant Outcomesa. A, QB16. Which of the following β‐blockers do you consider to be associated with weight gain? B, QB17. Which of the following β‐blockers do you consider to be associated with clinically relevant changes in glucose? aAll possible answers to this survey question are shown. *P < 0.05. PCP, primary care physician